Anatara Lifesciences Ltd (ASX:ANR) Annual Report 2022



The latest annual report of Anatara Lifesciences Ltd (ANR) was published on 30 Jun 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - ANR Annual Results

Amounts in AUD

Total Revenue
-
Gross Profit
-747.18k
EBIT
-2.53M
Net Tangible Assets
1.36M
Net Income
-2.53M
Capital Expenditures
-6.56k

ANR Income Statement 2022 Annual Report

As per the latest Income Statement of ANR, the Net revenue increased by $NaN (NaN%) compared to the previous period. The operating income in 2022 decreased by $-492788 (-24%). The net income as per the annual report was -2.53M which decreased by $-536419 (-27%) compared to previous year.

Income Statement Report (2022/2021)

2022 2021
Total Revenue - -
Gross Profit -747.18k -840.82k
Operating Income -2.53M -2.04M
Income Before Tax -2.53M -2M
Net Income -2.53M -2M

Balance Sheet - ANR 2022 Annual Report

Read further: ANR Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Anatara Lifesciences Ltd showed the company reduced the cash on balance sheet by $-2.31M (-67%). The Net tangible assets of ANR on the balance sheet were at 1.36M which is $-2.47M (-64%) less than previous annual report. The total stockholder equity also decreased by $-2.47M (-64%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

2022 2021
Cash 1.12M 3.43M
Total Assets 1.77M 4.33M
Long Term Debt - -
Total Liabilities 403.35k 496.67k
Total Shareholder Equity 1.36M 3.83M
Net Tangible Assets 1.36M 3.83M

Cash Flow Statement - ANR 2022 Annual Report

The 2022 annual cash flow statement of Anatara Lifesciences Ltd showed that the net income decreased by $-536419 (-27%) compared to previous reporting period. Also the capital expenditure of ANR decreased by $-2582 (-65%).

As of 2022, the total cash from investing activities was -56.56k and total cash from financing activities was -22.44k.

Cash Flow Statement Report (2022/2021)

2022 2021
Net Income -2.53M -2M
Capital Expenditures -6.56k -3.98k
Dividends Paid - -
Total Cash From From Investing Activities -56.56k -3.98k
Total Cash From From Financing Activities -22.44k 2.85M

Anatara Lifesciences Ltd Annual Report History

Income Statement

Income Statement history of Anatara Lifesciences Ltd (ASX:ANR)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Total Revenue - - - 663.4k
Cost Of Revenue 747.18k 840.82k 1.29M 776.26k
Gross Profit -747.18k -840.82k -1.29M -112.85k
Research Development - - - -
Selling General Administrative 2.28M 2.27M 2.92M 3.78M
Non Recurring - - - -
Other Operating Expenses -487.24k -1.07M -687.45k -877.57k
Total Operating Expenses 2.53M 2.04M 3.52M 3.67M
Operating Income -2.53M -2.04M -3.52M -3.01M
Total Other Income Expense Net 2.69k 46.32k 153.83k 142.5k
Ebit -2.53M -2.04M -3.52M -3.01M
Interest Expense -3.32k -300 -300 -300
Income Before Tax -2.53M -2M -3.36M -2.87M
Income Tax Expense - - - -
Minority Interest - - - -
Net Income From Continuing Ops -2.53M -2M -3.36M -2.87M
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income -2.53M -2M -3.36M -2.87M
Net Income Applicable To Common Shares -2.53M -2M -3.36M -2.87M

Balance Sheet Statement

Balance Sheet Statement history of Anatara Lifesciences Ltd (ASX:ANR)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Cash 1.12M 3.43M 2.68M 1.36M
Short Term Investments 50k - - 4.05M
Net Receivables 508.52k 772.56k 630.33k 895.99k
Other Current Assets 22.01k 37.12k 23.74k 49.02k
Total Current Assets 1.7M 4.24M 3.34M 6.36M
Property Plant Equipment 66.92k 85.03k 7.19k 20.2k
Total Assets 1.77M 4.33M 3.34M 6.38M
Accounts Payable 152.63k 195.63k 33.86k 116.76k
Other Current Liab 34.18k 36.67k 26.62k 33.17k
Other Liab 81 28.27k 22.93k 13.94k
Total Current Liabilities 358.13k 402.6k 464.03k 452.82k
Total Liab 403.35k 496.67k 486.96k 466.76k
Common Stock 19.91M 19.76M 17.04M 16.94M
Retained Earnings -18.98M -16.6M -14.74M -11.52M
Treasury Stock 439.49k 678.49k 553.34k 499.07k
Other Stockholder Equity 439.49k 678.49k 553.34k 499.07k
Total Stockholder Equity 1.36M 3.83M 2.86M 5.92M
Net Tangible Assets 1.36M 3.83M 2.86M 5.91M
Long Term Debt - - - -

Cash Flow Statement

Cash Flow Statement history of Anatara Lifesciences Ltd (ASX:ANR)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Net Income -2.53M -2M -3.36M -2.87M
Depreciation 24.68k 6.26k 16.1k 22.73k
Change To Netincome 74.79k 117.95k 305.46k 196.39k
Change To Account Receivables 264.03k -142.23k 265.65k 1.14M
Change To Liabilities -33.51k -76.91k 47.8k -54.96k
Change To Operating Activities -30.57k -6.68k 4.73k -677.8k
Total Cash From Operating Activities -2.23M -2.1M -2.72M -2.24M
Capital Expenditures -6.56k -3.98k -4.08k -4.08k
Investments -50k -50k 4.05M 2.15M
Total Cashflows From Investing Activities -56.56k -3.98k 4.05M 2.15M
Net Borrowings -17.44k -514 -514 -514
Other Cashflows From Financing Activities -5k -180.69k -180.69k -180.69k
Total Cash From Financing Activities -22.44k 2.85M 2.85M 2.85M
Change In Cash -2.31M 749.71k 1.32M -87.66k
Dividends Paid - - - -